Cargando…

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus

While it is a common practice to monitor complement levels in patients with systemic lupus erythematosus to aid in flare prediction and detection, it is unclear if this strategy is helpful in preventing subsequent organ damage. We studied longitudinal complement levels in 102 SLE patients during a m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raymond, Warren, Eilertsen, Gro, Nossent, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330819/ https://www.ncbi.nlm.nih.gov/pubmed/30687766 http://dx.doi.org/10.1155/2018/8051972

Ejemplares similares

Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation
por: Nossent, Johannes C, et al.
Publicado: (2016)

The Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
por: Raymond, Warren David, et al.
Publicado: (2019)

Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus
por: Raymond, Warren David, et al.
Publicado: (2021)

Prognostic Factors at Diagnosis Associated With Damage Accrual in Childhood-Onset Systemic Lupus Erythematosus Patients
por: Rodríguez-Lozano, Ana Luisa, et al.
Publicado: (2022)

High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
por: Koelmeyer, Rachel, et al.
Publicado: (2020)

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
por: Bruce, Ian N, et al.
Publicado: (2015)

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
por: Reid, Sarah, et al.
Publicado: (2020)

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts
por: Frodlund, M, et al.
Publicado: (2019)

Recurrent podocytopathy in a patient with systemic lupus erythematosus
por: Paramalingam, Shereen, et al.
Publicado: (2017)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
por: Piga, Matteo, et al.
Publicado: (2017)

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
por: Urowitz, Murray B., et al.
Publicado: (2022)

Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis
por: Becker-Merok, Andrea, et al.
Publicado: (2006)

LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2022)

Systemic Lupus Erythematosus Patients With Related Organic Damage Are at High Risk of Hypothyroidism
por: Ni, Jiajia, et al.
Publicado: (2022)

Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
por: Harden, Olivia C., et al.
Publicado: (2020)

STUDIES ON CHRONIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS WITH HYPOCOMPLEMENTEMIA
por: Michael, Alfred F., et al.
Publicado: (1971)

Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis
por: Miyachi, Kazusa, et al.
Publicado: (2023)

Epidemiology and Damage Accrual of Systemic Lupus Erythematosus in Central Sweden: A Single‐Center Population‐Based Cohort Study Over 14 Years From Östergötland County
por: Arkema, Elizabeth V., et al.
Publicado: (2023)

Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2013)

Hospitalisation for systemic lupus erythematosus associates with an increased risk of mortality in Australian patients from 1980 to 2014: a longitudinal, population-level, data linkage, cohort study
por: Raymond, Warren David, et al.
Publicado: (2021)

Evaluation of Thrombocytopenia in Systemic Lupus Erythematosus and Correlation with Different Organs Damages
por: Ktona, Ergeta, et al.
Publicado: (2014)

Osteoporosis in Systemic Lupus Erythematosus - Correlations with Disease Activity and Organ Damage
por: BARBULESCU, A., et al.
Publicado: (2015)

Independent association of glucocorticoids with damage accrual in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2016)

Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosis
por: Fukui, Shoichi, et al.
Publicado: (2016)

Analysis on the risk factors for organ damage in patients with systemic lupus erythematosus: a cross-sectional single-center experience
por: Živković, Valentina, et al.
Publicado: (2019)

Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus
por: Bonakdar, Zahra Sayed, et al.
Publicado: (2011)

Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort
por: Al Sawah, Sarah, et al.
Publicado: (2015)

Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis
por: Rossi, Giovanni Maria, et al.
Publicado: (2022)

Hypocomplementemia at Diagnosis of Antineutrophil Cytoplasmic Autoantibody Glomerulonephritis Is an Independent Risk Factor for a Worst Outcome
por: Lionaki, Sophia, et al.
Publicado: (2022)

Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2012)

Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay
por: Petrackova, Anna, et al.
Publicado: (2017)

The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus
por: Qiu, Wenlin, et al.
Publicado: (2022)

Risk Factors Analysis for the Development of Hypocomplementemia in Rheumatoid Arthritis Patients: A Single-Center Retrospective Study
por: Chen, Yinyi, et al.
Publicado: (2023)

Risk Factors in Cardiovascular Disease in Systemic Lupus Erythematosus
por: Sinicato, Nailú Angélica, et al.
Publicado: (2013)

Risk Factors for Thyroid Cancer in Systemic Lupus Erythematosus
por: Kawano, Yutaka, et al.
Publicado: (2017)

Complement levels and risk of organ involvement in patients with systemic lupus erythematosus
por: Gandino, Ignacio Javier, et al.
Publicado: (2017)

Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus
por: Bengtsson, Anders A, et al.
Publicado: (2014)

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States
por: Bell, Christopher F, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_91ickikup8nlcc3io9ipr7mhk2